- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 254.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 242.26M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 215.26M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$61.79M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$27.52M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $395.2M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $66.81M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $185.01M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $171.59M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $89.74M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $105.19M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$553.84M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$119.15M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$451.93M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$475.93M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $195.39M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $196.07M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.02B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $633.31M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $373.63M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $404.35M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $465.05M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $514.16M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$2.98 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$2.98 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $94.55M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $82.47M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $60.32M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $37.27M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$721.81M |
| Net Income | Q1 2026 · Mar 31, 2025 | $32K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$701.6M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $21.23M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $5.38M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $4.57M |